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Abstract
Objective. To analyze the requesting patterns for a range of laboratory tests ordered in 2009 from eight laboratories providing
services to eight health areas, using appropriate indicators.
Design. Indicators measured every test request per 1,000 inhabitants, and indicators that measured the number of tests per
related test requested by general practitioners were calculated. The savings generated, if each Health Care Department
achieved the appropriate indicator standard, were also calculated. Laboratory Information System registers were collected, and
indicators were calculated automatically in each laboratory using a data warehouse application.
Results. There was a large difference in demand for tests by health areas. The ratio of related tests also showed a great variability.
The savings generated if each Health Care Department had achieved the appropriate indicator standard were e172,116 for free
thyroxine, e18,289 for aspartate aminotransferase, and e62,678 for urea.
Conclusions. Considerable variability exists in general practitioners’ demand for laboratory tests.
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Introduction
Laboratory expenses have increased considerably in
recent years (1). The growing prominence of labora-
tory science in diagnostic practices (2) and informati-
on technology advances that enhance test accessibility
(3) increases test use. However, the same factors also
predispose to over-use and misuse.
Theproportionofinappropriatetestrequestsranges
from 4.5% to 95%, in studies of medical records (4)
using implicit and explicit criteria. These studies are
complex, difﬁcult to conduct, and generally not cost-
effective, because tests are usually a relatively low-
cost item. Studies to compare ordering behavior are a
less expensive way to obtain information useful for
optimizing laboratory test use.
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care in eight Health Care Departments of the Valencia
Health Agency in 2009 was evaluated in this study
using a range of pathology tests representing 90% of
requests in general practice to compare primary care
test ordering behavior.
Material and methods
The study was carried out under the auspices of the
Valencia Health Agency to compare 2009 tests
requested by general practitioners (GPs). The net-
work was created by issuing two surveys to 13 labo-
ratories (March 2008). The inclusion criteria were
a common laboratory information system (LIS)
(Omega, Roche Diagnostic
 
, Spain) and a data ware-
house application capable of stratifying LIS results
among clients (in-patients, primary care patients,
etc.). The eight laboratories included provide services
to hospitalized, emergency, specialized, and primary
care patients whose samples are obtained in primary
health care centers for hematology and blood chem-
istry tests. The population served in each Health Care
Department is shown in Table I. In stage 2, we
deﬁned and validated the registers and indicators
and created a common database. In stage 3 (March
2010), the results were presented conﬁdentially to
participating hospitals at a meeting. Each laboratory
representative knew only the identiﬁcation of
their own data. A 2-month period of reﬂection and
suggestions followed.
Table I. Tests/1,000 inhabitants in 2009 in different health care areas. These areas received health services from different Health Care
Departments to which the different laboratories participating in the study pertain.
Health care areas (total population December 2009)
A
(197,029)
B
(254,233)
C
(274,233)
D
(271,218)
E
(55,282)
F
(372,138)
G
(357,267)
H
(233,075)
General
Alanine aminotransferase 383 364 350 293 380 209 298 280
Alkaline phosphatase 85 149 54 117 73 75 113 98
Aspartate aminotransferase 169 224 140 107 95 202 298 280
Cholesterol 318 363 337 339 422 215 351 276
Creatinine 511 364 345 324 387 219 311 276
Gamma-glutamyltranspeptidase 156 341 314 106 376 193 249 267
Glucose 524 373 356 350 408 239 368 278
HDL cholesterol 228 239 200 250 306 199 329 207
Potassium 341 167 157 309 203 97 165 135
Total bilirubin 154 139 100 94 143 95 103 56
Triglycerides 317 361 333 338 423 199 348 275
Urea 381 112 91 145 117 212 285 56
Uric acid 313 340 329 173 363 183 293 265
Anemia proﬁle
Iron 102 207 86 89 100 52 185 73
Ferritin 92 146 87 87 118 45 121 110
Transferrin 38 15 59 12 78 10 34 19
Rheumatic proﬁle
C-reactive protein 167 147 54 58 115 110 71 75
Calcium 156 43 284 100 129 44 68 37
Phosphate 85 37 253 95 86 30 40 32
Rheumatoid factor 24 33 57 64 31 26 44 42
Thyroid proﬁle
Free thyroxine 95 110 42 18 68 117 74 42
Thyrotropin 152 140 160 82 226 117 147 100
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collected and indicators were calculated using a com-
puterapplicationbasedondatawarehouseandOnLine
Analytical Processing OLAP cubes (Omnium, Roche
Diagnostic
 
, Spain). Every test request per 1,000 inha-
bitants (22 chemistry tests) and the appropriate indica-
tors that measured the number of tests per related test
requested (aspartate aminotransferase/alanne amino-
transferase,urea/creatinine,freethyroxine/thyrotropin)
by GPs were calculated.
The savings generated, if each Health Care Depart-
ment achieved the appropriate indicator standard
(0.2 for aspartate aminotransferase/alanine amino-
transferase, 0.1 for urea/creatinine, and 0.25 for
thyroxine/thyrotropin), were also calculated (5).
Results
Table I shows the test requests per 1,000 inhabitants
per Health Care Department in 2009 grouped accord-
ing to the tests most used in primary care. There was
a large difference in demand for tests by health areas.
The appropriate indicators (ratio of related tests)
are shown in Table II. The ratio of related tests also
showed a great variability.
The savings generated, if each Health Care De-
partment had achieved the appropriate indicator
standard, were e253,083: e18,289 for aspartate ami-
notransferase, e62,678 for urea, and e172,116 for
thyroxine.
Discussion
Studies to evaluate clinical laboratory activities are a
tool increasingly used to compare performance
between organizations using the same measures and
the same measurement system. It took 2 years to set
up the laboratory network and data collection process
and to identify suitable indicators for comparing
primary care requesting performance.
Primarycaredemandfortestsisgrowing(6)interms
of requests per inhabitant or per doctor. Our results
demonstratethebroadvariabilityofdemandfortestsby
primary care on a test-by-test basis. It is not easy to
establish a relationship between variability and center
characteristics. All departments participating in the
study, except one, are in an urban and coastal zone
andarealsoinﬂuencedbyseasonaltourism.TheValen-
cian Community ranks the fourth most populated
autonomous community of Spain, in a very populated
country.Thereisnosigniﬁcantdifferencebetweenthe
percentages of population aged >65 years in different
centers. Five hospitals are university hospitals, but it is
not possible to establish a relationship between the
indicator values and the type of hospital.
Itisstrangetoobservethegreatdifferencesinserum
glucose requesting, and the duplicated demand for
potassium and sodium (the sodium results were not
reportedbecausetheywereidenticaltothepotassiumin
all Health Care Departments) from one health area to
another, where the prevalence of hypertension and
need for monitoring are probably similar. Probably,
different uses of lipids and uric acid measurements in
the prevention of hypercholesterolemia and metabolic
syndrome, respectively, will be responsible for large
differences in requests (7). Moreover, uric acid is
requested out of habit. In addition, despite evidence
to the contrary, most GPs believe that an annual phys-
ical examination detects subclinical illness (8). Many
report using laboratory tests for screening purposes
with little evidence to support the practice, although
it has become less frequent (9) as evidence-
based guidelines have come into use and medical
cost containment has become a concern.
Larsson et al. (5) recommend using serum alanine
aminotransferase and alkaline phosphatase as the only
liver markers and demonstrated the enormous savings
that would result from reducing demand for aspartate
aminotransferase, bilirubin, and gamma-glutamyl-
transpeptidase, which varied widely in the study.
Laboratory tests to diagnose anemia are subject to
both under-use and over-use (10). It is well known
Table II. Value of the appropriate indicators that measure the number of tests per related tests requested by General Practitioners in different
Health Care Departments.
Health care areas
ABCDEFGH
Key Performance Indicator (KPI)
Aspartate amino transferase/ Alanine amino transferase 0.435 0.611 0.404 0.372 0.246 0.962 1.000 1.000
Urea / Creatinine 0.725 0.285 0.283 0.455 0.298 0.968 0.918 0.198
Free thyroxine / Thyrotropin 0.587 0.701 0.269 0.255 0.306 1.000 0.504 0.419
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anemia investigation. However, it is surprising that
certain departments are requesting from 3 to 10 times
more iron than transferrin tests. Despite the iron test
being cheap, its uselessness as an isolated test and the
high within-person biological variation of serum iron
indicate that early establishment of corrective mea-
sures is required to reduce its isolated request and to
highlight the need for iron and transferrin to be used
in combination. It is an archaic habit, important to
change soon.
Thevariabilityinrequestsforrheumaticandthyroid
disease tests is also noteworthy; for instance, free
thyroxin is requested despite evidence that it may be
generated after abnormal thyrotropin in primary care
patients.There is also ahuge differencein the request-
ingpatternsofcalcium,possiblyan‘under-used’testin
some areas. Treatable primary hyperparathyroidism
disease in patients who are generally free of somatic
manifestations is most often diagnosed when routine
biochemical testing shows an elevated serum calcium
level. The advent of automated laboratory serum
analyzers in the 1960s allowed for the detection of
‘asymptomatic hypercalcemia’, and the incidence of
hyperparathyroidism increased 5-fold during the next
two decades. However, nowadays hyperparthyroidism
can be again overlooked due to the disappearance of
analyzers of continuous type. Calcium is a parameter
whose use should be encouraged.
Probably,highdemandforC-reactiveproteintestsin
area A indicated more frequent use to detect/monitor
infectious/rheumatoid diseases, when compared to
other areas.
In certain health areas, urea and creatinine requests
were similar, and transferase requests were identical
(1:1 demand ratio). However, there is evidence indi-
cating that serum urea provides little more informa-
tion than serum creatinine alone (11), as also applies
to the two transferases. We only studied the economic
effects of decreasing three serum chemistry test ratios,
and the total savings would be great. If we use these
ﬁgures to calculate the total savings for all health care
areas in Valencian Community, and more tests ratios,
it would represent an enormous saving.
The great differences observed in the study in all
test requests in such a large population are inconsis-
tent with the goal of providing equitable care and
apparently reﬂect local traditions (5). The differences
are probably due to individual variations in clinical
practice; however, they still undermine laboratory
cost-effectiveness efforts and could be changed
(12), preferably through regional strategies developed
by consensus between GPs and clinical pathologists
and formalized in health care governance measures.
Given the large difference in requesting patterns
between health areas, the ﬁrst step in optimizing
laboratory test use would be to establish basic reﬂex
testing strategies. Implementation of these measures
would then be monitored using appropriate indica-
tors, which actually vary greatly from one district to
another, after setting clear goals. Nowadays most tests
are added by automated analysers in accordance with
algorithms. Previous process mapping will be needed
in less automated laboratories. Laboratory directors
should be aware that any strategy implemented to
reduce inappropriate test use will reduce the number
of tests processed by personnel and will appear to
diminish theoretical performance. However, higher-
quality diagnostic information would be obtained. In
addition, unexpected results and false positives would
decrease, and, concomitantly, so would the number
of diagnostic tests performed and specialist consulta-
tions required for their interpretation, which are an
important source of anxiety for patients. This is where
the contribution of laboratory professionals is critical,
by providing fewer, more selective, optimally effective
diagnostic data.
Laboratorydataareinvolvedin70%ofclinicaldeci-
sions (13); however, laboratory costs usually account
for a very small proportion of overall health care costs.
Patients should receivethe full beneﬁt from laboratory
medicine, and it is important to encourage the use of
some tests, such as serum calcium.
This study revealed that considerable variability
exists in the use of laboratory tests by eight health
areas. It also identiﬁed appropriate indicators that
can be applied across a spectrum of clinical labora-
tories, and which thus may be useful for examining
requesting patterns. The study highlighted the need
to unify demand by optimizing the use of appropriate
tests through interdepartmental communication and
rigorous application of scientiﬁc evidence (14).
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